pcDNA3.1 Foxp1A Citations (4)
Originally described in: Foxp1 is an essential transcriptional regulator of B cell development.Hu H, Wang B, Borde M, Nardone J, Maika S, Allred L, Tucker PW, Rao A Nat Immunol. 2006 Aug . 7(8):819-26. PubMed Journal
Articles Citing pcDNA3.1 Foxp1A
| Articles |
|---|
| FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness. Neyroud D, Nosacka RL, Callaway CS, Trevino JG, Hu H, Judge SM, Judge AR. J Cachexia Sarcopenia Muscle. 2021 Apr;12(2):421-442. doi: 10.1002/jcsm.12666. Epub 2021 Feb 1. PubMed |
Production of human entorhinal stellate cell-like cells by forward programming shows an important role of Foxp1 in reprogramming.
Bergmann T, Liu Y, Skov J, Mogus L, Lee J, Pfisterer U, Handfield LF, Asenjo-Martinez A, Lisa-Vargas I, Seemann SE, Lee JTH, Patikas N, Kornum BR, Denham M, Hyttel P, Witter MP, Gorodkin J, Pers TH, Hemberg M, Khodosevich K, Hall VJ.
Front Cell Dev Biol. 2022 Aug 15;10:976549. doi: 10.3389/fcell.2022.976549. eCollection 2022.
PubMed
Associated Plasmids |
| FoxP1 Represses MEF2A in Striated Muscle. Steiman S, Miyake T, McDermott JC. Mol Cell Biol. 2024;44(2):57-71. doi: 10.1080/10985549.2024.2323959. Epub 2024 Mar 14. PubMed |
| Analysis of TGFbeta1-Induced activin A gene expression in kidney mesangial cells. Soomro A, Nmecha IK, Trink J, Li R, Krepinsky JC. Front Mol Biosci. 2025 Sep 23;12:1607043. doi: 10.3389/fmolb.2025.1607043. eCollection 2025. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.